STUDY DESIGN: Prospective, single-arm interventional cohort. OBJECTIVE: To evaluate the safety and effectiveness of balloon kyphoplasty to treat symptomatic vertebral body compression fractures (VCFs). SUMMARY OF BACKGROUND DATA: VCFs treated nonoperatively can diminish function and quality of life, and lead to chronic health effects. The short-term safety and effectiveness of balloon kyphoplasty for symptomatic VCFs are well-documented, but long-term follow-up is needed. METHODS: A total of 155 elderly patients with symptomatic VCFs were enrolled in a prospective, multicenter treatment study of balloon kyphoplasty at 19 geographically diverse US centers. Outcomes included back pain severity, bedrest, and limited activities because of back pain, back disability score, and SF-36 Medical Outcomes Survey, at 7 days (visual analog scale only), and 1, 3, 12, and 24 months after treatment. RESULTS: Patients reported severe back pain (15/20 on visual analog scale) interfering with daily activities 90% of days per month before kyphoplasty. Physical functioning and quality of life were also markedly impaired. Statistically significant (P < 0.001) improvements occurred in all pain, functional, and mental health outcomes at the first follow-up after treatment and were maintained for 24 months. CONCLUSIONS: Elderly patients with symptomatic VCFs had rapid, significant, and sustained improvements in back pain, back function, and quality of life following balloon kyphoplasty.
STUDY DESIGN: Prospective, single-arm interventional cohort. OBJECTIVE: To evaluate the safety and effectiveness of balloon kyphoplasty to treat symptomatic vertebral body compression fractures (VCFs). SUMMARY OF BACKGROUND DATA: VCFs treated nonoperatively can diminish function and quality of life, and lead to chronic health effects. The short-term safety and effectiveness of balloon kyphoplasty for symptomatic VCFs are well-documented, but long-term follow-up is needed. METHODS: A total of 155 elderly patients with symptomatic VCFs were enrolled in a prospective, multicenter treatment study of balloon kyphoplasty at 19 geographically diverse US centers. Outcomes included back pain severity, bedrest, and limited activities because of back pain, back disability score, and SF-36 Medical Outcomes Survey, at 7 days (visual analog scale only), and 1, 3, 12, and 24 months after treatment. RESULTS:Patients reported severe back pain (15/20 on visual analog scale) interfering with daily activities 90% of days per month before kyphoplasty. Physical functioning and quality of life were also markedly impaired. Statistically significant (P < 0.001) improvements occurred in all pain, functional, and mental health outcomes at the first follow-up after treatment and were maintained for 24 months. CONCLUSIONS: Elderly patients with symptomatic VCFs had rapid, significant, and sustained improvements in back pain, back function, and quality of life following balloon kyphoplasty.
Authors: Leon Siang Shen Foo; William Yeo; Stephanie Fook; Chang Ming Guo; John Li Tat Chen; Wai Mun Yue; Seang Beng Tan Journal: Eur Spine J Date: 2007-07-21 Impact factor: 3.134
Authors: M Reinhold; C Knop; R Beisse; L Audigé; F Kandziora; A Pizanis; R Pranzl; E Gercek; M Schultheiss; A Weckbach; V Bühren; M Blauth Journal: Unfallchirurg Date: 2009-02 Impact factor: 1.000